Baby KJ’s Gene-Editing Miracle: First-of-Its-Kind CRISPR Treatment Saves His Life!

A Rare and Deadly Diagnosis

• ⚠️ Baby KJ Muldoon was diagnosed with CPS1 deficiency, a deadly and rare genetic disorder affecting one in 1.3 million babies.
• 🔬 This condition prevents the body from breaking down nitrogen, leading to a toxic buildup of ammonia in the blood.
• 💔 For severe cases like KJ's, the prognosis is often tragic, with half not surviving infancy.

Groundbreaking CRISPR Therapy

• 🏥 Doctors at the Children's Hospital of Philadelphia rapidly developed a solution when existing drugs failed.
• 🧬 They utilized CRISPR gene-editing technology to precisely find and repair genetic mistakes.
• 💡 This marked the first time CRISPR was used to create a completely bespoke therapy for a single patient with CPS1 deficiency.

A Personalized Medical Moonshot

• 🚀 At just 7 months old, KJ received the world's first CRISPR-based treatment for CPS1 deficiency, engineered entirely in-house.
• 🧪 The therapy was infused directly into KJ's bloodstream, representing a medical moonshot with no prior cases or guarantees.

Miraculous Recovery and Discharge

• ✅ Slowly and miraculously, the treatment worked, causing KJ's body to stabilize and ammonia levels to subside.
• 📈 KJ's weight increased, energy returned, and he began developing like a healthy baby.
• 🥳 After 307 days in the hospital, KJ was discharged, celebrated by staff and family, marking a significant milestone.

Paving the Way for Future Medicine

• 🌱 KJ's personalized therapy, designed from scratch, paves the way for hundreds of other children with similar rare diseases.
• 🌟 This story offers a glimpse into the future of genetic medicine, where personalized treatment can address even the rarest conditions.
• 💖 KJ's life is a testament to human determination and scientific ingenuity, transforming what was once impossible into achievable hope.